Making US workers pass genetic test data to employers is wrong
By Martina Cornel,
New Scientist
| 03. 17. 2017
A proposed law effectively allowing US employers to require workers to take DNA tests and hand over the results is misguided
Letting companies require workers to have genetic tests and disclose the results sounds practically dystopian. But that’s the effect of a new congressional bill in the US.
Employees can refuse to comply, but risk being penalised by having to fork out thousands of dollars in extra health insurance payments – the threat of which might be enough to coerce them into going along with it.
This inflammatory proposal has been backed by Republican members of the House of Representatives Committee on Education and the Workforce.
With US employers funding a large chunk of employees’ health insurance, they may, understandably, want to rule out staff having certain health risks, which would in turn keep premiums down. Sure, genetic tests can quantify some of those risks. But the bill blows a huge hole in the principle that genetic testing should be voluntary and directly undermines the US Genetic Information and Non-Discrimination Act (GINA).
What’s more, many of the risk-reducing options...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...